A detailed history of Carnegie Capital Asset Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Carnegie Capital Asset Management, LLC holds 103,646 shares of PFE stock, worth $2.75 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
103,646
Previous 110,025 5.8%
Holding current value
$2.75 Million
Previous $3.08 Million 2.57%
% of portfolio
0.09%
Previous 0.1%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$27.7 - $31.39 $176,698 - $200,236
-6,379 Reduced 5.8%
103,646 $3 Million
Q2 2024

Jul 19, 2024

SELL
$25.26 - $29.6 $943,738 - $1.11 Million
-37,361 Reduced 25.35%
110,025 $3.08 Million
Q1 2024

May 03, 2024

BUY
$25.89 - $29.73 $309,592 - $355,511
11,958 Added 8.83%
147,386 $4.09 Million
Q4 2023

Jan 29, 2024

SELL
$26.13 - $33.94 $1.34 Million - $1.74 Million
-51,315 Reduced 27.48%
135,428 $3.9 Million
Q3 2023

Oct 10, 2023

SELL
$32.09 - $37.51 $483,500 - $565,163
-15,067 Reduced 7.47%
186,743 $6.19 Million
Q2 2023

Aug 04, 2023

BUY
$36.12 - $41.79 $419,967 - $485,892
11,627 Added 6.11%
201,810 $7.4 Million
Q1 2023

Apr 19, 2023

SELL
$39.39 - $51.28 $1.8 Million - $2.35 Million
-45,761 Reduced 19.39%
190,183 $7.76 Million
Q4 2022

Jan 23, 2023

BUY
$41.75 - $54.5 $358,883 - $468,482
8,596 Added 3.78%
235,944 $0
Q3 2022

Oct 13, 2022

BUY
$43.76 - $53.42 $45,116 - $55,076
1,031 Added 0.46%
227,348 $9.95 Million
Q2 2022

Aug 02, 2022

BUY
$46.53 - $55.17 $1.82 Million - $2.15 Million
39,015 Added 20.83%
226,317 $11.9 Million
Q2 2022

Jul 13, 2022

SELL
$46.53 - $55.17 $1.34 Million - $1.58 Million
-28,729 Reduced 13.3%
187,302 $7.33 Million
Q1 2022

Apr 11, 2022

BUY
$45.75 - $56.69 $818,284 - $1.01 Million
17,886 Added 9.03%
216,031 $11.2 Million
Q4 2021

Jan 21, 2022

BUY
$41.32 - $61.25 $180,320 - $267,295
4,364 Added 2.25%
198,145 $11.7 Million
Q3 2021

Oct 08, 2021

BUY
$39.25 - $50.42 $254,300 - $326,671
6,479 Added 3.46%
193,781 $8.34 Million
Q2 2021

Jul 16, 2021

BUY
$35.91 - $40.68 $743,265 - $841,994
20,698 Added 12.42%
187,302 $7.33 Million
Q1 2021

Apr 12, 2021

SELL
$33.49 - $37.77 $343,473 - $387,369
-10,256 Reduced 5.8%
166,604 $6.04 Million
Q4 2020

Feb 08, 2021

BUY
$33.47 - $42.56 $233,687 - $297,153
6,982 Added 4.11%
176,860 $6.51 Million
Q3 2020

Oct 13, 2020

SELL
$31.75 - $37.25 $206,089 - $241,789
-6,491 Reduced 3.68%
169,878 $6.23 Million
Q2 2020

Jul 09, 2020

SELL
$30.12 - $36.54 $81,143 - $98,438
-2,694 Reduced 1.5%
176,369 $5.77 Million
Q1 2020

May 08, 2020

SELL
$27.03 - $38.62 $579,036 - $827,317
-21,422 Reduced 10.69%
179,063 $5.83 Million
Q4 2019

Feb 13, 2020

SELL
$32.92 - $37.36 $1.82 Million - $2.06 Million
-55,138 Reduced 21.57%
200,485 $7.86 Million
Q3 2019

Nov 20, 2019

SELL
$32.49 - $42.13 $344,458 - $446,662
-10,602 Reduced 3.98%
255,623 $9.19 Million
Q2 2019

Jul 24, 2019

BUY
$36.98 - $41.52 $121,405 - $136,310
3,283 Added 1.25%
266,225 $11.5 Million
Q1 2019

May 14, 2019

BUY
$37.5 - $41.2 $5.11 Million - $5.62 Million
136,345 Added 107.7%
262,942 $11.2 Million
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $1.29 Million - $1.47 Million
-33,543 Reduced 20.95%
126,597 $5.53 Million
Q3 2018

Nov 27, 2018

BUY
$34.47 - $41.81 $1.31 Million - $1.59 Million
38,133 Added 31.25%
160,140 $6.97 Million
Q2 2018

Aug 16, 2018

BUY
$32.98 - $35.16 $256,518 - $273,474
7,778 Added 6.81%
122,007 $4.97 Million
Q1 2018

May 15, 2018

BUY
$31.91 - $37.02 $196,661 - $228,154
6,163 Added 5.7%
114,229 $4.06 Million
Q4 2017

Feb 12, 2018

BUY
$33.26 - $35.29 $479,276 - $508,528
14,410 Added 15.39%
108,066 $3.78 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $74,214 - $81,755
2,394 Added 2.62%
93,656 $3.41 Million
Q2 2017

Aug 14, 2017

BUY
N/A
91,262
91,262 $3.01 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Carnegie Capital Asset Management, LLC Portfolio

Follow Carnegie Capital Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carnegie Capital Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carnegie Capital Asset Management, LLC with notifications on news.